{
  "story_id": "6591ff75b3ae0374bb5523a7759cad2d",
  "desk": "drm3",
  "revision": 4,
  "published_at": "2026-09-04T14:01:41.000Z",
  "content_hash": "916133b0134339dcb8c856ad6f0a5b08b152240cf23a80b01c80a0ffad4e302e",
  "hash_basis": "sha256 over `headline\\ndek\\nprose`, plus `\\n` + the canonical citations JSON when any source is placed, plus `\\n#blog` for blogs",
  "basis": {
    "headline": "New Zealand Approves Pharmaceutical-Grade MDMA for PTSD Treatment",
    "dek": "New Zealand regulators have approved pharmaceutical-grade MDMA combined with psychotherapy for treating severe PTSD.",
    "prose": "New Zealand health regulator Medsafe approved on Friday the prescription of pharmaceutical-grade MDMA for treating severe post-traumatic stress disorder (PTSD). [^1][^2]\n\nNew Zealand becomes the second country in the world to approve MDMA for PTSD treatment, following Australia which approved the use in 2023. [^3][^8] The approved treatment protocol involves administering MDMA in combination with psychotherapy within a controlled clinical environment under the supervision of an authorized psychiatrist. [^4] Vice-Premier David Seymour stated that New Zealand is determined to make innovative treatments more accessible and described PTSD as a condition that destroys lives and is difficult to treat. [^5]\n\nThe Ministry of Health indicated that MDMA-assisted treatment will be combined with psychotherapy and that patients, who must be over 18, will not be given drugs to take home. [^6] Deputy Prime Minister David Seymour stated that PTSD ruins lives and is difficult to treat, and that MDMA can be very effective at treating it through psychedelic-assisted therapy. [^7][^10] The authorization is limited to two psychiatrists who must demonstrate experience in the field and follow specific protocols for administering MDMA to patients. [^9]",
    "cited": "[{\"statement\":\"New Zealand health regulator Medsafe approved on Friday the prescription of pharmaceutical-grade MDMA for treating severe post-traumatic stress disorder (PTSD).\",\"source\":\"Berlingske\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-04T02:15:44.000Z\",\"publisher_count\":1,\"sources\":[\"Berlingske\"]},{\"statement\":\"Two psychiatrists in New Zealand obtained authorization on Friday to prescribe pharmaceutical-grade MDMA to individuals suffering from severe post-traumatic stress disorder (PTSD).\",\"source\":\"El Economista\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-04T03:03:11.000Z\",\"publisher_count\":1,\"sources\":[\"El Economista\"]},{\"statement\":\"New Zealand becomes the second country in the world to approve MDMA for PTSD treatment, following Australia which approved the use in 2023.\",\"source\":\"Berlingske\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-04T02:15:44.000Z\",\"publisher_count\":1,\"sources\":[\"Berlingske\"]},{\"statement\":\"The approved treatment protocol involves administering MDMA in combination with psychotherapy within a controlled clinical environment under the supervision of an authorized psychiatrist.\",\"source\":\"Berlingske\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-04T02:15:44.000Z\",\"publisher_count\":1,\"sources\":[\"Berlingske\"]},{\"statement\":\"Vice-Premier David Seymour stated that New Zealand is determined to make innovative treatments more accessible and described PTSD as a condition that destroys lives and is difficult to treat.\",\"source\":\"Berlingske\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-04T02:15:44.000Z\",\"publisher_count\":1,\"sources\":[\"Berlingske\"]},{\"statement\":\"The Ministry of Health indicated that MDMA-assisted treatment will be combined with psychotherapy and that patients, who must be over 18, will not be given drugs to take home.\",\"source\":\"El Economista\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-04T03:03:11.000Z\",\"publisher_count\":1,\"sources\":[\"El Economista\"]},{\"statement\":\"Deputy Prime Minister David Seymour stated that PTSD ruins lives and is difficult to treat, and that MDMA can be very effective at treating it through psychedelic-assisted therapy.\",\"source\":\"Medical Xpress\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-04T08:49:33.000Z\",\"publisher_count\":1,\"sources\":[\"Medical Xpress\"]},{\"statement\":\"New Zealand is the second country after Australia to authorize MDMA treatment for PTSD; Australia allowed MDMA and psilocybin in certain clinical contexts in 2023.\",\"source\":\"Primera Hora\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-04T14:01:41.000Z\",\"publisher_count\":1,\"sources\":[\"Primera Hora\"]},{\"statement\":\"The authorization is limited to two psychiatrists who must demonstrate experience in the field and follow specific protocols for administering MDMA to patients.\",\"source\":\"Primera Hora\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-04T14:01:41.000Z\",\"publisher_count\":1,\"sources\":[\"Primera Hora\"]},{\"statement\":\"Seymour added that MDMA can be very effective for treating PTSD through substance-assisted psychedelic therapy and that New Zealand is committed to expanding access to innovative treatments.\",\"source\":\"El Economista\",\"instrument\":\"News\",\"claim_key\":null,\"published_at\":\"2026-09-04T03:03:11.000Z\",\"publisher_count\":1,\"sources\":[\"El Economista\"]}]",
    "kind": "news"
  },
  "receipt_verify": "Ed25519 over the dot-joined string `slice_hash.cursor_from.cursor_to.view.view_version.row_count`; public_key and sig are base64url of the raw 32-byte key / 64-byte signature",
  "receipt": null,
  "receipt_note": "this revision predates receipt-keeping (before v0.37.0); the filed row lives in the record",
  "generation_chain": {
    "wire": {
      "stream": "fountain_news",
      "story_id": "d1cb65f0cae063a7f9bbe8ba3e28c834",
      "thread_id": "bf2de6cdd73495e07cd44c7c06703ac1",
      "thread_label": "Medsafe",
      "novelty": "UPDATE",
      "content_hash": "0966374940d90dc37295deac0435e1bdce65ea2dc42912504878bac0cfa7845d",
      "last_published_at": "2026-09-04T14:01:41.000Z",
      "read_receipt": {
        "slice_hash": "dab3a215e15932106cac4353092860e8dde2e2217b043cda22542163b7eb7ba1",
        "cursor_from": "eyJ0cyI6IjIwMjYtMDktMDRUMTI6NTg6MjcuMDAwMDAwWiIsImlkIjoiNzRkY2VlNGQ3ZDQ0YWVkNzBjYThkNTUwOTgyNmE0ODIiLCJ2IjoiMSJ9",
        "cursor_to": "eyJ0cyI6IjIwMjYtMDktMDRUMTU6NDk6MDAuMDAwMDAwWiIsImlkIjoiMDdlZmFkYTBjNWUzYzY1MmUyYjNmMmYxNGE5YzNlYzAiLCJ2IjoiMSJ9",
        "view": "v_fountain_news",
        "view_version": "1",
        "row_count": 100,
        "window_days": 3,
        "bytes_scanned": 9795940,
        "credits": 8,
        "price_per_100_rows": 8,
        "sig": "7okHfjGz_4W4pXcH4n3yPkpeQKByTdnsKs38XFNjTQHcc02N16lntD-NQU7OQbYk28blmn5ON-p3b_USletXDA",
        "public_key": "bMUigy8O0jOnBxQ4Sc-5lwhIZ8LQVAhxMbR7qESVuUE",
        "signer_path": "lakehouse/data-extract/v1",
        "alg": "Ed25519",
        "signed": true
      },
      "compose": 3,
      "recomposed_at": "2026-09-05T19:05:58.320Z"
    },
    "written_at": "2026-09-04T18:21:34.818Z"
  },
  "cited_facts": [
    {
      "n": 1,
      "statement": "New Zealand health regulator Medsafe approved on Friday the prescription of pharmaceutical-grade MDMA for treating severe post-traumatic stress disorder (PTSD).",
      "source": "Berlingske",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 2,
      "statement": "Two psychiatrists in New Zealand obtained authorization on Friday to prescribe pharmaceutical-grade MDMA to individuals suffering from severe post-traumatic stress disorder (PTSD).",
      "source": "El Economista",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 3,
      "statement": "New Zealand becomes the second country in the world to approve MDMA for PTSD treatment, following Australia which approved the use in 2023.",
      "source": "Berlingske",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 4,
      "statement": "The approved treatment protocol involves administering MDMA in combination with psychotherapy within a controlled clinical environment under the supervision of an authorized psychiatrist.",
      "source": "Berlingske",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 5,
      "statement": "Vice-Premier David Seymour stated that New Zealand is determined to make innovative treatments more accessible and described PTSD as a condition that destroys lives and is difficult to treat.",
      "source": "Berlingske",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 6,
      "statement": "The Ministry of Health indicated that MDMA-assisted treatment will be combined with psychotherapy and that patients, who must be over 18, will not be given drugs to take home.",
      "source": "El Economista",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 7,
      "statement": "Deputy Prime Minister David Seymour stated that PTSD ruins lives and is difficult to treat, and that MDMA can be very effective at treating it through psychedelic-assisted therapy.",
      "source": "Medical Xpress",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 8,
      "statement": "New Zealand is the second country after Australia to authorize MDMA treatment for PTSD; Australia allowed MDMA and psilocybin in certain clinical contexts in 2023.",
      "source": "Primera Hora",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 9,
      "statement": "The authorization is limited to two psychiatrists who must demonstrate experience in the field and follow specific protocols for administering MDMA to patients.",
      "source": "Primera Hora",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    },
    {
      "n": 10,
      "statement": "Seymour added that MDMA can be very effective for treating PTSD through substance-assisted psychedelic therapy and that New Zealand is committed to expanding access to innovative treatments.",
      "source": "El Economista",
      "instrument": "News",
      "claim_key": null,
      "url": null,
      "occurred_at": null,
      "published_at": null
    }
  ],
  "note": "A signature proves who filed this and that it has not changed since. It never makes a claim true. The dates on cited_facts (occurred_at, published_at) are the forge's, joined at read time; they are not part of the signed basis above."
}